Chika Shigeyasu Selected Research

tear proteins

5/2021	Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation.
11/2015	Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chika Shigeyasu Research Topics

Disease

8	Dry Eye Syndromes (Dry Eye Syndrome) 05/2021 - 01/2012
2	Keratitis 02/2022 - 07/2012
1	Corneal Perforation 02/2022
1	Lacrimal Duct Obstruction 05/2021
1	Pruritus (Itching) 10/2018
1	Mycoses (Diseases, Fungus) 08/2018
1	Ulcer 08/2018
1	Corneal Ulcer 08/2018
1	Alacrima 01/2018
1	Congenital Alacrima 01/2018
1	Pain (Aches) 10/2016
1	Breast Neoplasms (Breast Cancer) 10/2016
1	Ductal Carcinoma 10/2016
1	Prolapse 01/2015
1	Glaucoma 01/2012
1	Cataract (Cataracts) 01/2012
1	Inflammation (Inflammations) 01/2012
1	Disease Progression 01/2012
1	Rupture 01/2009
1	Wounds and Injuries (Trauma) 01/2009

Drug/Important Bio-Agent (IBA)

4	Ophthalmic Solutions (Eye Drops)IBA 10/2018 - 07/2013
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 11/2016
3	MucinsIBA 08/2018 - 11/2015
2	tear proteinsIBA 05/2021 - 11/2015
2	Fluorescein (Funduscein)FDA LinkGeneric 09/2020 - 10/2016
2	diquafosolIBA 11/2016 - 11/2015
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2016 - 11/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2018
1	SecretagoguesIBA 08/2018
1	SuspensionsIBA 08/2018
1	rebamipideIBA 08/2018
1	Pharmaceutical PreparationsIBA 01/2017
1	Muramidase (Lysozyme)IBA 11/2016
1	Secretory Immunoglobulin A (SIgA)IBA 11/2016
1	LactoferrinIBA 11/2016
1	Lipocalin 1IBA 11/2016
1	Cytotoxins (Cytolysins)IBA 10/2016
1	Immunoconjugates (Immunoconjugate)IBA 10/2016
1	human ERBB2 proteinIBA 10/2016
1	Ado-Trastuzumab EmtansineIBA 10/2016
1	SodiumIBA 11/2015
1	Therapeutic UsesIBA 07/2013
1	Voriconazole (Vfend)FDA LinkGeneric 07/2012
1	Amphotericin B (Amphotericin)FDA LinkGeneric 07/2012
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2012
1	FluorocarbonsIBA 01/2009
1	Retinaldehyde (Retinal)IBA 01/2009

Therapy/Procedure

4	Contact Lenses 02/2022 - 07/2012
2	Slit Lamp 08/2018 - 01/2015
1	Aftercare (After-Treatment) 02/2022
1	Therapeutics 10/2018
1	Bandages (Bandage) 10/2016
1	Corneal Transplantation (Keratoplasty) 10/2016
1	Punctal Plugs 01/2012
1	Vitrectomy 01/2009